Effectiveness of a computerized clinical decision support system for prevention of glucocorticoid-induced osteoporosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effectiveness of a computerized clinical decision support system for prevention of glucocorticoid-induced osteoporosis ; volume:12 ; number:1 ; day:2 ; month:9 ; year:2022 ; pages:1-10 ; date:12.2022
Scientific reports ; 12, Heft 1 (2.9.2022), 1-10, 12.2022
- Urheber
-
Morikawa, Toru
Sakuma, Mio
Nakamura, Tsukasa
Sonoyama, Tomohiro
Matsumoto, Chisa
Takeuchi, Jiro
Ohta, Yoshinori
Kosaka, Shinji
Morimoto, Takeshi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-19079-7
- URN
-
urn:nbn:de:101:1-2022112009411388716032
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Morikawa, Toru
- Sakuma, Mio
- Nakamura, Tsukasa
- Sonoyama, Tomohiro
- Matsumoto, Chisa
- Takeuchi, Jiro
- Ohta, Yoshinori
- Kosaka, Shinji
- Morimoto, Takeshi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Glucocorticoid induced osteoporosis : 12 tables
Glucocorticoid-induced osteoporosis: an update
Linking glucocorticoid-induced osteoporosis to osteoimmunology
Osteoporosis : diagnosis, prevention, therapy
Nutrition and Osteoporosis Prevention
Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice
The critical role of T cells in glucocorticoid-induced osteoporosis
Computerized Clinical Decision Support: Will it Transform Healthcare?
Intramembranous ossification and endochondral ossification are impaired differently between glucocorticoid-induced osteoporosis and estrogen deficiency-induced osteoporosis
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Glucocorticoid induced osteoporosis : 12 tables
Glucocorticoid-induced osteoporosis: an update
Linking glucocorticoid-induced osteoporosis to osteoimmunology
Osteoporosis : diagnosis, prevention, therapy
Nutrition and Osteoporosis Prevention
Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice
The critical role of T cells in glucocorticoid-induced osteoporosis
Computerized Clinical Decision Support: Will it Transform Healthcare?
Intramembranous ossification and endochondral ossification are impaired differently between glucocorticoid-induced osteoporosis and estrogen deficiency-induced osteoporosis
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Glucocorticoid induced osteoporosis : 12 tables
Glucocorticoid-induced osteoporosis: an update
Linking glucocorticoid-induced osteoporosis to osteoimmunology
Osteoporosis : diagnosis, prevention, therapy
Nutrition and Osteoporosis Prevention
Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice
The critical role of T cells in glucocorticoid-induced osteoporosis
Computerized Clinical Decision Support: Will it Transform Healthcare?
Intramembranous ossification and endochondral ossification are impaired differently between glucocorticoid-induced osteoporosis and estrogen deficiency-induced osteoporosis
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis